Advanced search
Publication Cover
Postgraduate Medicine Volume 103, 1998 - Issue 5
Submit an article Journal homepage
21
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Inflammatory bowel disease

1. Origins, presentation, and course

Peter L. Moses Dr Moses and Dr Ferrentino are assistant professors and Dr Vecchio is associate professor and head, section of gastroenterology and hepatology; and Dr Moore is clinical instructor, department of medicine; University of Vermont College of Medicine, Burlington. Dr Bensen is assistant professor, Dartmouth Medical School, Hanover, New Hampshire, and a member of the department of gastroenterology, Veterans Administration Medical Center, White River Junction, Vermont.
, MD,
Brad R. Moore Dr Moses and Dr Ferrentino are assistant professors and Dr Vecchio is associate professor and head, section of gastroenterology and hepatology; and Dr Moore is clinical instructor, department of medicine; University of Vermont College of Medicine, Burlington. Dr Bensen is assistant professor, Dartmouth Medical School, Hanover, New Hampshire, and a member of the department of gastroenterology, Veterans Administration Medical Center, White River Junction, Vermont.
, MD,
Nicholas Ferrentino Dr Moses and Dr Ferrentino are assistant professors and Dr Vecchio is associate professor and head, section of gastroenterology and hepatology; and Dr Moore is clinical instructor, department of medicine; University of Vermont College of Medicine, Burlington. Dr Bensen is assistant professor, Dartmouth Medical School, Hanover, New Hampshire, and a member of the department of gastroenterology, Veterans Administration Medical Center, White River Junction, Vermont.
, MD,
Steven P. Bensen Dr Moses and Dr Ferrentino are assistant professors and Dr Vecchio is associate professor and head, section of gastroenterology and hepatology; and Dr Moore is clinical instructor, department of medicine; University of Vermont College of Medicine, Burlington. Dr Bensen is assistant professor, Dartmouth Medical School, Hanover, New Hampshire, and a member of the department of gastroenterology, Veterans Administration Medical Center, White River Junction, Vermont.
, MD &
James A. Vecchio Dr Moses and Dr Ferrentino are assistant professors and Dr Vecchio is associate professor and head, section of gastroenterology and hepatology; and Dr Moore is clinical instructor, department of medicine; University of Vermont College of Medicine, Burlington. Dr Bensen is assistant professor, Dartmouth Medical School, Hanover, New Hampshire, and a member of the department of gastroenterology, Veterans Administration Medical Center, White River Junction, Vermont.
, MD
Pages 77-102 | Published online: 30 Jun 2015

References

  • Mendeloff AI. Newer concepts of IBD epidemiology. In: Rachmilewitz D, ed. Inflammatory bowel diseases: proceedings of the International Symposium on Inflammatory Bowel Diseases, Jerusalem, September 7–9, 1981. Boston: Kluwer, 1982:137–42
  • Gilat T, Grossman A, Fireman Z, et al. Inflammatory bowel disease in Jews. In: McConnell RB, Rozen R, Langman M, et al, eds. The genetics and epidemiology of inflammatory bowel disease. Vol 11. New York: Karger, 1986:135–40
  • Calkins BM, Lilienfeld AM, Garland CF, et al. Trends in incidence rates of ulcerative colitis and Crohn's disease. Dig Dis Sci 1984;29(10):913–20
  • Yang H, Shohat T, Rotter JI. The genetics of inflammatory bowel disease. In: MacDermott RP, Stenson WF, eds. Inflammatory bowel disease. New York: Elsevier, 1992:17
  • Farmer RG, Michener WM, Mortimer EA. Studies of family history among patients with inflammatory bowel disease. Clin Gastroenterol 1980;9(2):271–7
  • Neigut D, Proujansky R, Trucco M, et al. Association of an HLA-DQB-1 genotype with Crohn's disease in children. (Abstr) Gastroenterology 1992;102(4 Pt 2):A671
  • Toyoda H, Wang SJ, Yang HY, et al. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 1993; 104(3):741–8
  • Duerr RH, Targan SR, Landers CJ, et al. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis: comparison with other colitides/diarrheal illnesses. Gastroenterology 1991; 100(6):1590–6
  • MacDermott RP. Alterations in the mucosal immune system in ulcerative colitis and Crohn's disease. Med Clin North Am 1994;78(6): 1207–31
  • Teahon K, Smethurst P, Levi AJ, et al. Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut 1992;33(3):320–3
  • Wolf JL, Rubin DH, Finberg R, et al. Intestinal M cells: a pathway for entry of reovirus into the host. Science 1981; 212(4493):471–2
  • Hanson LA, Ahlstedt S, Andersson B, et al. The biologie properties of secretory IgA. J Reticuloendothel Soc 1980; 28(Suppl):1-9S
  • Mestecky J, McGhee JR. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 1987; 40:153–245
  • Underdown BJ, Schiff JM. Immunoglobulin A: strategic defense initiative at the mucosal surface. Annu Rev Immunol 1986;4:389–417
  • Nielsen OH, Elmgreen J, Ahnfelt-Ronne I. Serum interferon activity in inflammatory bowel disease: arachidonic acid release and lipoxygenation activated by alpha-class interferon in human neutrophils. Inflammation 1988;12(2):169–79
  • Brandtzaeg P, Sollid LM, Thrane PS, et al. Lymphoepithelial interactions in the mucosal immune system. Gut 1988;29(8): 1116–30
  • Tornasi TB Jr, Tan EM, Soloman A, et al. Characteristics of an immune system common to certain external secretions. J Exp Med 1965;121(1):101–24
  • Owen RL, Jones AL. Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles. Gastroenterology 1974; 66(2):189–203
  • Schreiber S, Raedler A, Stenson WF, et al. The role of the mucosal immune system in inflammatory bowel disease. Gastroenterol Clin North Am 1992;21 (2):451–502
  • Kirschner BS. Does acute infection trigger chronic inflammation in pediatric patients with chronic inflammatory bowel disease? Gastroenterology 1993;104(4 Pt 2):A725
  • Schumacher G, Kollberg B, Sandstedt B, et al. A prospective study of first attacks of inflammatory bowel disease and non-relapsing colitis: microbiologic findings. Scand J Gastroenterol 1993;28(12):1077–85
  • Ku¨hn R, Löhler J, Rennick D, et al. Interleukin-lO-deficient mice develop chronic enterocolitis. Cell 1993;75(2):263–74
  • Sadlack B, Merz H, Schorle H, et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993; 75(2):253–61
  • Farmer RG, Hawk WA, Turnbull RB Jr. Regional enteritis of the colon: a clinical and pathologic comparison with ulcerative colitis. Am J Dig Dis 1968;13(6):501–14
  • Watts JM, De Dombal FT, Watkinson G, et al. Early course of ulcerative colitis. Gut 1966;7(1):16–31
  • Both H, Torp-Pedersen K, Kreiner S, et al. Clinical appearance at diagnosis of ulcerative colitis and Crohn's disease in a regional patient group. Scand J Gastroenterol 1983; 18(7):987–91
  • Ogorek CP, Fisher RS. Differentiation between Crohn's disease and ulcerative colitis. Med Clin North Am 1994; 78(6)1249–58
  • Jewel DP. Ulcerative colitis in gastrointestinal disease. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal disease: pathophysiology, diagnosis, management. 5th ed. Philadelphia: Saunders, 1993: 1305–30
  • Kornbluth A, Salomon P, Sachar DB. Crohn's disease in gastrointestinal disease. In: Sleisenger, Fordtran, eds, 28 p 1270–1304
  • Hanauer SB, Shulman MI. Inflammatory bowel disease: new therapeutic approaches. Gastroenterol Clin North Am 1995;24(3):523–40
  • Kirsner JB. Problems in the differentiation of ulcerative colitis and Crohn's disease of the colon: the need for repeated diagnostic evaluation. (Editorial) Gastroenterology 1975;68(1):187–91
  • Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report of a therapeutic trial. Br Med J 1955;2:1041

References

  • Mogadam M, Dobbins WO 3d, Korelitz BI, et al. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology 1981;80(1):72–6
  • Korelitz BI, Adler DJ, Mendelsohn RA, et al. Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease. Am J Gastroenterol 1993; 88(8):1198–205
  • Sandborn WJ. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate. Am J Gastroenterol 1996;91(3):423–33
  • Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330(26): 1841–5
  • Brynskov J, Freund L, Rasmussen SN, et al. A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med 1989;321(13):845–50
  • Brynskov J, Freund L, Nørby Rasmussen S, et al. Final report on a placebo- controlled, double-blind, randomized, multicentre trial of cyclosporin treatment in active chronic Crohn's disease. Scand J Gastroenterol 1991;26(7):689–95
  • Canadian Crohn's Relapse Prevention Trial Investigators. Low-dose cyclosporine for the treatment of Crohn's disease. N Engl J Med 1994;330(26):1846–51
  • Van Gossum A, Schmit A, Adler M, et al. Administration of cyclosporine in acute severe ulcerative colitis: short-term efficacy and long-term outcome. (Abstr)Gastroenterology 1996;110(4):A1035
  • Feagan BG, Rochon J, Fedorak RN, et al for the North American Crohn's Study Group Investigators. Methotrexate for the treatment of Crohn's disease. N Engl J Med 1995;332(5):292–7
  • Peppercorn MA. Are antibiotics useful in the management of nontoxic severe ulcerative colitis? J Clin Gastroenterol 1993; 17(1):14–7
  • Spirt MJ. Antibiotics in inflammatory bowel disease: new choices for an old disease. Am J Gastroenterol 1994;89(7):974–8
  • Thayer WR, Reinert SE, Natarajan R, et al. Rifabutin/streptomycin in the treatment of Crohn's disease: a double-blind controlled trial. (Abstr) Gastroenterology 1996;110(4):A1027
  • Sutherland L, Singleton J, Sessions J, et al. Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut 1991;32(9): 1071–5
  • Brandt LJ, Bernstein LH, Boley SJ, et al. Metronidazole therapy for perineal Crohn's disease: a follow-up study. Gastroenterology 1982;83(2):383–7
  • Peppercorn MA. Is there a role for antibiotics as primary therapy in Crohn's ileitis? J Clin Gastroenterol 1993;17(3): 235–7
  • Rubin PH, Chapman ML, Scherl E, et al. Clarithromycin in active Crohn's disease (CD): preliminary results of open label pilot study. (Abstr) Gastroenterology 1996; 110(4):A1005
  • Lofberg R, Danielsson A, Salde L. Oral budesonide in active Crohn's disease. Aliment Pharmacol Ther 1993;7(6):611–6
  • Moellmann HW, Hochhaust G, Tromm A, et al. Pharmacokinetics and evaluation of systemic side effects of budesonide after oral administration of modified release capsules in healthy volunteers, ileostoma patients and patients with Crohn's disease. (Abstr) Gastroenterology 1996;110(4):A972
  • Danielsson A, Lofberg R, Persson T, et al. A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis. Scand J Gastroenterol 1992;27(1):9–12
  • Danish Budesonide Study Group. Budesonide enema in distal ulcerative colitis: a randomized dose-response trial with prednisolone enema as positive control. Scan J Gastroenterol 1991;26(12): 1225–30
  • Lofberg R, Danielsson A, Suhr O, et al. Oral budesonide versus prednisolone in patients with active extensive and left- sided ulcerative colitis. Gastroenterology 1996;110(6):1713–8
  • Harries AD, Baird A, Rhodes J. Nonsmoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) 1982;284(6317):706
  • Calkins B, Lilienfeld A, Mendeloff A, et al. Smoking factors in ulcerative colitis and Crohn's disease in Baltimore. (Abstr) Am J Epidemiol 1984;120(3):A498
  • Pullan RD, Rhodes J, Ganesh S, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994; 330(12):811–5
  • Dupas JL, Brazier F, Yzet T, et al. Treatment of active Crohn's disease with heparin. (Abstr) Gastroenterology 1996; 110(4):A900
  • Cordum NR, Scholerb P, Sutton D, et al. Oral glutamine supplementation in patients with Crohn's disease with or without glucocorticoid treatment. (Abstr) Gastroenterology 1996;110(4):A888
  • Scheppach W. Are short-chain fatty acids effective in the local treatment of ulcerative colitis? (Abstr) Gastroenterology 1996;110(4):A1010
  • Breuer RI, Soergel KH, Lashner BA, et al. Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomized, placebo-controlled trial. (Abstr) Gastroenterology 1996;110(4):A873

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.